Brief: Camurus: CHMP Recommends Approval Of Oczyesa For Treatment Of Acromegaly In The EU
25/04/2025 15:02
April 25 (Reuters) - Camurus AB CAMX.ST: CHMP RECOMMENDS APPROVAL OF OCZYESA® FOR TREATMENT OF ACROMEGALY IN THE EU Source text: ID:nWkrQD29y Further company coverage: CAMX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Camurus AB
See all newsBrief: Camurus Receives Approval In Canada For Oczyesa XR
Brief: Executive Sells About £279,000 Of Camurus Shares
Jefferies cuts Ipsen to 'underperform' on Somatuline competition risk
Brief: Camurus Says NDA Resubmission For CAM2029 In Acromegaly Accepted For Review By FDA
Camurus shares rise after Q2 revenue, operating profit beat